Skip to main content

Considerations for Viral Disease Eradication Lessons Learned and Future Strategies: Workshop Summary (2002) / Chapter Skim
Currently Skimming:

Appendix B: Workshop Agenda
Pages 183-189

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 183...
... Director, Division of Vaccines and Immunization Pan American Health Organization, Washington, DC Session I: Case Studies of Major Eradication or Elimination Efforts This session will address the standards and strategies, technical feasibility, political will, and financial commitment for several diseases targeted for eradication or elimination. Discussions will identify the successes and failures of these efforts, and the challenges for post-eradication/elimination strategies.
Read the entire page →
From page 184...
... Director, Center for Civilian Biodefense Studies The Johns Hopkins University, Baltimore, MD 10:30 Break 10:45 The next target after polio: Global eradication of measles Stephen Cochi, M.D., M.P.H. Director, Vaccine-Preventable Disease Eradication Division National Immunization Program, Centers for Disease Control and Prevention, Atlanta GA 11:15 Eradication of congenital rubella syndrome Stanley A
Read the entire page →
From page 185...
... Cohen, M.D Head, Medical Virology Section, Laboratory of Clinical Investigation National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD Adjourn public session Friday, February 2, 2001 Continental Breakfast 8:00 Opening remarks loshua Lederberg, Ph.D. Chair, Forum on Emerging Infections Session m Challenges to Post-Eradication Operational and Institutional Remediation The need for resources will likely increase for countries with multiple eradication campaigns, particularly as disease prevalence decreases and surveillance intensifies.
Read the entire page →
From page 186...
... Professor Emeritus, Department of International Health School of Hygiene and Public Health, The Johns Hopkins University, Baltimore, MD Laboratory security and regulations governing viral .
Read the entire page →
From page 187...
... Professor and Chair, Department of Molecular Microbiology and Immunology School of Hygiene and Public Health, The Johns Hopkins University, Baltimore, MD 12:15 The potential role of probiotics and microbial ecology in host defense Susanna Cunningham-Rundles, Ph.D. Professor of Immunology Weill Medical College of Cornell University, New York, NY 12:45 Lunch :p 187 Session V: The Response to Post-Eradication Outbreaks Protecting populations that are no longer immune presents formidable challenges to public health agencies, pharmaceutical manufacturers, security analysts, and the public.
Read the entire page →
From page 188...
... Senior Fellow, The Johns Hopkins Center for Civilian Biodefense Studies Former CEO, Georgetown Medical Center 2:00 Vaccines for post-elimination (eradications contingencies Thomas Monath, M.D. Vice President, Research and Medical Affairs Acambis Inc.
Read the entire page →
From page 189...
... Chair, Forum on Emerging Infections Margaret Hamburg, M.D., Assistant Secretary for Planning and Evaluation, U.S. Department of Health and Human Services Gail Cassell, Vice President, Infectious Diseases, Drug Discovery Research and Clinical Investigation, Eli Lilly & Company, Indianapolis, IN Michael Osterholm, Chairman and CEO, Infection Control Advisory Network, Inc., Eden Prairie, MN Stephen Teret AD, Professor, Program on Law and Public Health, The Johns Hopkins School of Hygiene and Public Health, Baltimore, MD Samuel L
Read the entire page →

Key Terms

  • emerging infections
  • international health
  • nobel laureate
  • infections sackler
  • continental breakfast

  • biodefense studies
  • clinical investigation
  • joshua lederberg
  • american health
  • sackler foundation

  • civilian biodefense
  • foundation scholar
  • child survival
  • infectious diseases
  • pan american

  • break session
  • health school
  • senior fellow
  • roy anderson
  • college school

  • health consultant
  • hopkins center
  • disease prevalence
  • consultant task
  • facing disease

  • anderson chair
  • welicome fund
  • former ceo
  • drug discovery
  • disease epiclemiology


    • This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
    More information on Chapter Skim is available.